CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report
January 8, 2004
| Delaware | 0-19131 | 52-1555759 |
| (State or other jurisdiction of | (Commission File No.) | (I.R.S. Employer Identification No.) |
| incorporation or organization) |
35 West Watkins Mill
Road, Gaithersburg, MD 20878
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code (301) 417-0770
ITEM 5. Other Events
On January 8, 2004, MedImmune, Inc. (the "Company"), issued a press release announcing the departure of Gregory S. Patrick, Senior Vice President and Chief Financial Officer. A copy of the Company's press release describing this event is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
ITEM 7. Exhibits
c. Exhibits
Ex. 99.1 - Press release, dated January 8, 2004, "MedImmune Announces Departure of Chief Financial Officer"
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BY: /s/ Lota S. Zoth —————————————— Lota S. Zoth Vice President and Controller Principal Accounting Officer |
Dated: January 8, 2004